Du'lac Care ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  19.6% 11.5% 7.2% 5.9% 8.3%  
Credit score (0-100)  7 21 32 39 28  
Credit rating  B BB BBB BBB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  71 0 0 0 0  
Gross profit  12.7 152 77.5 449 290  
EBITDA  1.4 16.0 24.3 79.7 -11.9  
EBIT  1.4 12.7 19.3 74.7 -16.9  
Pre-tax profit (PTP)  1.4 12.3 17.7 69.1 -38.2  
Net earnings  1.1 9.2 11.4 55.4 -37.1  
Pre-tax profit without non-rec. items  1.4 12.3 17.7 69.1 -38.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 21.7 16.7 11.7 6.7  
Shareholders equity total  21.1 30.3 41.8 97.1 60.0  
Interest-bearing liabilities  0.0 0.0 64.2 41.8 23.2  
Balance sheet total (assets)  40.6 131 225 314 287  

Net Debt  -40.6 -110 -3.5 -113 -108  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  71 0 0 0 0  
Net sales growth  0.0% -100.0% 0.0% 0.0% 0.0%  
Gross profit  12.7 152 77.5 449 290  
Gross profit growth  0.0% 1,095.8% -49.1% 479.1% -35.3%  
Employees  1 1 1 3 1  
Employee growth %  0.0% 0.0% 0.0% 200.0% -66.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  41 131 225 314 287  
Balance sheet change%  0.0% 223.5% 70.9% 39.9% -8.6%  
Added value  1.4 16.0 24.3 79.7 -11.9  
Added value %  2.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 18 -10 -10 -10  

Net sales trend  0.0 -1.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  2.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  2.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  11.2% 8.3% 24.9% 16.6% -5.8%  
Net Earnings %  1.5% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  1.5% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  1.9% 0.0% 0.0% 0.0% 0.0%  
ROA %  3.5% 14.4% 10.6% 27.6% -5.6%  
ROI %  6.8% 47.7% 27.5% 60.1% -15.0%  
ROE %  5.1% 36.0% 31.7% 79.7% -47.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  51.9% 23.1% 18.6% 30.9% 20.9%  
Relative indebtedness %  27.4% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  -29.5% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -2,845.1% -685.0% -14.3% -142.1% 901.1%  
Gearing %  0.0% 0.0% 153.8% 43.0% 38.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 3.9% 10.2% 65.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  2.1 1.1 0.9 1.2 1.0  
Current Ratio  2.1 1.1 1.1 1.4 1.2  
Cash and cash equivalent  40.6 109.8 67.7 155.1 130.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  56.9% 0.0% 0.0% 0.0% 0.0%  
Net working capital  21.1 9.3 25.7 88.0 54.8  
Net working capital %  29.5% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  71 0 0 0 0  
Added value / employee  1 16 24 27 -12  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1 16 24 27 -12  
EBIT / employee  1 13 19 25 -17  
Net earnings / employee  1 9 11 18 -37